Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Phone counseling helps latinas navigate cancer risk

NCT ID NCT01230346

First seen Nov 11, 2025 · Last updated Jun 23, 2026 · Updated 33 times

Summary

This study tests whether a culturally-informed telephone counseling program can help Latina women at high risk for hereditary breast or ovarian cancer learn more about their risk and feel more in control. About 493 women with a personal or family history of these cancers will take part. The goal is to see if this approach reduces anxiety and improves knowledge compared to standard care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NO EVIDENCE OF DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • City of Hope Medical Center

    Duarte, California, 91010, United States

  • Olive View-UCLA Medical Center

    Sylmar, California, 91342, United States

  • University of Southern California-Keck School of Medicine

    Los Angeles, California, 90033, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

counseling intervention

What this could lead to

If successful, this could show that a tailored phone counseling program helps Latinas better understand their cancer risk and feel more in control.

What could go wrong

This is a pilot study focused on education and decision-making, not a treatment. It may not change health outcomes or be widely adopted.

Conditions

The condition(s) this trial relates to.

breast-ovarian cancer, familial, susceptibility to, 1 breast-ovarian cancer, familial, susceptibility to, 2 familial ovarian carcinoma hereditary breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.